Blood Donor Specimen Testing for Tripler Army Medical Center, Hawaii

This is a Source Sought Notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified sources; (2) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. The NAICS code is 621511 and the size standard is $32.5M. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a small-business set-aside is possible.

Tripler Army Medical Center (TAMC) is seeking qualified sources to provide the non-personal services of Blood Donor Specimen Testing Services.

If awarded, this will be a firm-fixed price contract where the work will be required on an as needed basis. The contract term, if awarded, will be a one-year base period and four (4) one-year option periods. The anticipated start date of the base period of performance is 1 October 2016. The Government reserves the right to exercise the option years to extend the contract term.

The Contractor shall be required to perform the following services and meet the minimum requirements as stated below:

The contractor shall provide the non-personal services of blood donor specimen testing services for Tripler Army Medical Center (TAMC), Hawaii. The contractor shall provide all required facilities, personnel, services, transportation materials, equipment, and supplies required. Blood donor testing services will support the U.S. Army, U.S. Navy, U.S. Air Force, Veteran's Administration, Coast Guard, and other Federal Government Agencies. All tests shall be executed at the contractor's premises, or within the contractor's network of laboratories (affiliate or qualified subcontractor). The standard test panel will be in accordance with the Food and Drug Administration regulations for the manufacturing of transfusable blood products will include at least:

ABO/RH (including weak-D testing)
Antibody screen
Standard Test for Syphilis (STS)
HBsAg
HBcAb
Anti-HCV
HIV 1 and 2
HTLV I and II
Chagas testing
CMV
WNV NAT
HCV NAT
HBV NAT

The confirmatory testing will consist of individually run tests:

Antibody Identification
HBsAg Confirmatory
HCV Confirmatory
HIV 1/2 Confirmatory
HTLV I/II Confirmatory
Chagas Confirmatory

***CONTRACTORS MUST BE ABLE TO MEET THE FOLLOWING TURNAROUND TIMES***
Results must be faxed upon completion of the testing and (verification of results for accuracy) within 20 hours from time of receipt of specimen and no later than 40 hours from time of shipment of specimen in order to meet the MEDCOM requirement to provide fresh blood to theater. Confirmation tests will be available based upon the requirements established by the specific testing procedure.

All qualified sources are invited to submit capability statements that substantiate their experience and qualifications in performing services. Interested firms shall indicate if they have provided similar services to military medical treatment facilities and/or the general public under terms and conditions similar to those stated in this notice.

Responses to this notice should include company name, address, and telephone number, point of contact (POC), and brochures which will allow the Government to understand your service offerings and options. Submit capability statements to Mr. Lee Miyashiro, email lee.h.miyashiro.civ@mail.mil. Telephone responses will not be accepted. Responses must be received no later than 15 August 2016 at 10:00 a.m. Hawaiian Standard Time.

Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.